Are you incorporating ArteraAI for risk stratification and treatment for prostate cancer?
ArteraAI is now listed as level 1 by NCCN guidelines for evidence of validation as a risk stratification tool
Community PollStarted
Are you incorporating ArteraAI for risk stratification and treatment for prostate cancer?
94 physicians have voted
Join Mednetto vote and see how they answered.